Claritas Pharmaceuticals Stock Toronto S.E.
Equities
KLY
CA1806341071
Biotechnology & Medical Research
Sales 2019 | - | Sales 2020 | - | Capitalization | 13.65M 18.64M |
---|---|---|---|---|---|
Net income 2019 | -21M -28.68M | Net income 2020 | 4M 5.46M | EV / Sales 2019 | - |
Net Debt 2019 | 704K 961K | Net Debt 2020 | 920K 1.26M | EV / Sales 2020 | - |
P/E ratio 2019 |
-0.9
x | P/E ratio 2020 |
3.17
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 99.74% |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |